128 related articles for article (PubMed ID: 8546533)
1. Factors associated with Pneumocystis carinii pneumonia in Wegener's granulomatosis.
Godeau B; Mainardi JL; Roudot-Thoraval F; Hachulla E; Guillevin L; Huong Du LT; Jarrousse B; Remy P; Schaeffer A; Piette JC
Ann Rheum Dis; 1995 Dec; 54(12):991-4. PubMed ID: 8546533
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
Ognibene FP; Shelhamer JH; Hoffman GS; Kerr GS; Reda D; Fauci AS; Leavitt RY
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 1):795-9. PubMed ID: 7881673
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis.
Jarrousse B; Guillevin L; Bindi P; Hachulla E; Leclerc P; Gilson B; Rémy P; Rossert J; Jacquot C; Nilson B [corrected to Gilson B]
Clin Exp Rheumatol; 1993; 11(6):615-21. PubMed ID: 8299252
[TBL] [Abstract][Full Text] [Related]
4. Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis.
Hugle B; Solomon M; Harvey E; James A; Wadhwa A; Amin R; Bell-Peter A; Benseler S
Arthritis Care Res (Hoboken); 2010 Nov; 62(11):1661-4. PubMed ID: 20583109
[TBL] [Abstract][Full Text] [Related]
5. [Pneumocystis pneumonia among patients with systemic diseases].
Khellaf M; Godeau B
Presse Med; 2009 Feb; 38(2):251-9. PubMed ID: 19062243
[TBL] [Abstract][Full Text] [Related]
6. [Is the risk of pneumocystosis predictable in Wegener's disease?].
Godeau B; Mainardi JL; Hachulla E; Guillevin L; Roudot-Thoraval F; Remy P; Huong-Boutin LT; Schaeffer A; Piette JC
Rev Med Interne; 1993; 14(10):1025. PubMed ID: 8009021
[TBL] [Abstract][Full Text] [Related]
7. Granulomatous Pneumocystis carinii pneumonia in Wegener's granulomatosis.
Ullmer E; Mayr M; Binet I; Ebnöther-Staub C; Dalquen P; Solèr M; Tamm M
Eur Respir J; 2000 Jan; 15(1):213-6. PubMed ID: 10678649
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis carinii pneumonia in patients with connective tissue disease.
Li J; Huang XM; Fang WG; Zeng XJ
J Clin Rheumatol; 2006 Jun; 12(3):114-7. PubMed ID: 16755237
[TBL] [Abstract][Full Text] [Related]
9. A case of granulomatosis with polyangiitis complicated by cyclophosphamide toxicity and opportunistic infections: choosing between Scylla and Charybdis.
Ernst E; Girndt M; Pliquett RU
BMC Nephrol; 2014 Feb; 15():28. PubMed ID: 24495297
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases.
Godeau B; Coutant-Perronne V; Le Thi Huong D; Guillevin L; Magadur G; De Bandt M; Dellion S; Rossert J; Rostoker G; Piette JC
J Rheumatol; 1994 Feb; 21(2):246-51. PubMed ID: 8182632
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.
Ward MM; Donald F
Arthritis Rheum; 1999 Apr; 42(4):780-9. PubMed ID: 10211894
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis jiroveci pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin.
Hof H; Schnülle P
Mycoses; 2008; 51 Suppl 1():65-7. PubMed ID: 18471163
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.
Chung JB; Armstrong K; Schwartz JS; Albert D
Arthritis Rheum; 2000 Aug; 43(8):1841-8. PubMed ID: 10943875
[TBL] [Abstract][Full Text] [Related]
14. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy.
Lv J; Zhang H; Cui Z; Su T; Zhang Y; Wang H
Nephrol Dial Transplant; 2008 Sep; 23(9):2868-72. PubMed ID: 18463325
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of Pneumocystis carinii pneumonia in children with systemic lupus erythematosus].
Tang XY; Li J; Dong F; Song HM
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):920-4. PubMed ID: 24495763
[TBL] [Abstract][Full Text] [Related]
16. Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis.
Vincent F; Bensoussan TA
Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1424. PubMed ID: 7551403
[No Abstract] [Full Text] [Related]
17. Prognostic factors of Pneumocystis pneumonia in patients with systemic autoimmune diseases.
Kageyama T; Furuta S; Ikeda K; Kagami SI; Kashiwakuma D; Sugiyama T; Umibe T; Watanabe N; Yamagata M; Nakajima H
PLoS One; 2019; 14(3):e0214324. PubMed ID: 30908547
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for prevention.
Sowden E; Carmichael AJ
BMC Infect Dis; 2004 Oct; 4():42. PubMed ID: 15488151
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients].
Armbruster C; Hassl A; Kriwanek S
Wien Klin Wochenschr; 1998 Sep; 110(17):604-7. PubMed ID: 9816629
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults.
Gerrard JG
Med J Aust; 1995 Mar; 162(5):233-5. PubMed ID: 7891601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
